COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ — Lahjavida Bio, a biotechnology company pioneering a new class of tumor-targeted small ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

A Zenas Biopharma drug met the main goals of a pivotal clinical trial testing it as a treatment for a chronic inflammatory disorder with limited treatment options, but with results that raise ...

Decades ago, patients who were diagnosed with acute myeloid leukemia, a rare cancer of the bone marrow and blood, were told there was nothing doctors could do for them. In part due to pioneering ...

Joe Buczek is manager of digital content and promotion at CBS Detroit. He previously worked at WWTV, the Grand Traverse Insider, the Leader and the Kalkaskian, the Oakland Press and the Morning Sun.

Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, ...

President Donald Trump signed an executive order on Thursday, Dec. 18, to push forward with reclassifying marijuana under federal law to a less restrictive category. Trump's order does not immediately ...

CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials ...

Chicago-based Amphix Bio has raised $12.5 million in seed funding to advance its experimental paralysis-reversing drug toward human trials, the Northwestern University spinout announced today. The ...